CANCER-THERAPY, VOMITING, AND ANTIEMETICS

被引:56
作者
STEWART, DJ [1 ]
机构
[1] UNIV OTTAWA,FAC HLTH SCI,OTTAWA K1N 6N5,ONTARIO,CANADA
关键词
D O I
10.1139/y90-045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:304 / 313
页数:10
相关论文
共 130 条
[1]   DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].
AAPRO, MS ;
PLEZIA, PM ;
ALBERTS, DS ;
GRAHAM, V ;
JONES, SE ;
SURWIT, EA ;
MOON, TE .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471
[2]  
AGOSTINUCCI WA, 1986, CLIN PHARMACY, V5, P150
[3]   ANTI-EMETIC EFFICACY AND TOXICITY OF NABILONE, A SYNTHETIC CANNABINOID, IN LUNG-CANCER CHEMOTHERAPY [J].
AHMEDZAI, S ;
CARLYLE, DL ;
CALDER, IT ;
MORAN, F .
BRITISH JOURNAL OF CANCER, 1983, 48 (05) :657-663
[4]   THE GASTROINTESTINAL-TRACT IN CHEMOTHERAPY-INDUCED EMESIS - A FINAL COMMON PATHWAY [J].
AKWARI, OE .
DRUGS, 1983, 25 :18-34
[5]   SMALL INTESTINAL MUCOSAL TOXICITY OF CISPLATINUM - COMPARISON OF TOXICITY WITH PLATINUM ANALOGS AND DEXAMETHASONE [J].
ALLAN, SG ;
SMYTH, JF .
BRITISH JOURNAL OF CANCER, 1986, 53 (03) :355-360
[6]   DEFINITIONAL ISSUES IN THE STUDY OF ANTICIPATORY NAUSEA IN CANCER-CHEMOTHERAPY [J].
ANDRYKOWSKI, MA .
JOURNAL OF BEHAVIORAL MEDICINE, 1986, 9 (01) :33-41
[7]   ANTIEMETIC EFFECT OF ORAL VERSUS INTRAVENOUS METOCLOPRAMIDE IN PATIENTS RECEIVING CISPLATIN - A RANDOMIZED, DOUBLE-BLIND TRIAL [J].
ANTHONY, LB ;
KROZELY, MG ;
WOODWARD, NJ ;
HAINSWORTH, JD ;
HANDE, KR ;
BRENNER, DE ;
GRECO, FA ;
BURISH, TG .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (01) :98-103
[8]  
ANTONIO JDS, 1984, J CLIN HEMATOL ONCOL, V14, P55
[9]  
Artim R, 1983, P AN M AM SOC CLIN, V2, P85
[10]   ADVANCES IN ANTI-EMETIC THERAPY [J].
BAKOWSKI, MT .
CANCER TREATMENT REVIEWS, 1984, 11 (03) :237-256